MCLAREN MACOMB
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $195K
- Transactions
- 158
- Companies
- 21
- Average per transaction
- $1,237
Who reported the payments
| Medical Device Business Services, Inc. | $46,250 |
| Grifols Therapeutics LLC | $27,741 |
| Novartis | $25,060 |
| Abbott | $20,967 |
| ZOLL Circulation Inc | $13,445 |
| Depuy Synthes Products, Inc. | $9,241 |
| AstraZeneca | $8,358 |
| Inari Medical, Inc. | $7,500 |
| Linvatec Corporation | $6,251 |
| Boehringer Ingelheim | $6,246 |
| Johnson & Johnson | $6,175 |
| Stryker | $4,496 |
| B. Braun Medical Inc. | $4,150 |
| Smith+Nephew | $2,424 |
| Acell, Inc. | $2,156 |
| Edwards Lifesciences | $2,000 |
| Amgen | $1,500 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | $1,000 |
| Angiodynamics, Inc. | $349 |
| Hikma Pharmaceuticals USA | $143 |
| Siemens Medical Solutions USA, Inc. | $47 |